Summit Therapeutics, Inc. (SMMT)
16.76
+0.06
(+0.39%)
USD |
NASDAQ |
Oct 02, 16:00
16.75
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Price : 16.76 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 16.96 | 17.32 | 16.66 | 16.76 | 5.196M |
| Oct 01, 2026 | 16.82 | 17.50 | 16.59 | 16.69 | 7.901M |
| Sep 30, 2026 | 16.59 | 17.72 | 16.17 | 16.91 | 13.06M |
| Sep 29, 2026 | 18.91 | 19.09 | 16.15 | 16.39 | 27.34M |
| Sep 28, 2026 | 15.50 | 15.82 | 15.18 | 15.48 | 6.151M |
| Sep 25, 2026 | 16.45 | 16.58 | 15.55 | 15.61 | 3.808M |
| Sep 24, 2026 | 16.37 | 16.78 | 16.09 | 16.38 | 5.045M |
| Sep 23, 2026 | 17.10 | 17.46 | 16.25 | 16.45 | 3.891M |
| Sep 22, 2026 | 16.97 | 17.50 | 16.79 | 17.12 | 4.617M |
| Sep 21, 2026 | 18.40 | 18.42 | 16.64 | 16.90 | 5.781M |
| Sep 18, 2026 | 17.74 | 17.87 | 17.31 | 17.85 | 13.06M |
| Sep 17, 2026 | 17.73 | 18.10 | 17.42 | 17.72 | 6.135M |
| Sep 16, 2026 | 17.50 | 17.75 | 17.11 | 17.30 | 6.088M |
| Sep 15, 2026 | 18.16 | 18.47 | 17.11 | 17.40 | 5.797M |
| Sep 14, 2026 | 18.07 | 18.83 | 17.97 | 18.42 | 7.067M |
| Sep 11, 2026 | 17.20 | 17.70 | 17.14 | 17.55 | 4.278M |
| Sep 10, 2026 | 17.30 | 17.62 | 16.80 | 17.00 | 4.221M |
| Sep 09, 2026 | 18.20 | 18.32 | 17.24 | 17.54 | 4.804M |
| Sep 08, 2026 | 17.43 | 17.69 | 16.97 | 17.28 | 7.355M |
| Sep 04, 2026 | 16.94 | 17.63 | 16.80 | 17.60 | 6.946M |
| Sep 03, 2026 | 15.52 | 17.35 | 15.52 | 17.13 | 14.92M |
| Sep 02, 2026 | 14.15 | 14.72 | 14.06 | 14.60 | 3.779M |
| Sep 01, 2026 | 13.38 | 14.48 | 13.37 | 14.16 | 4.703M |
| Aug 31, 2026 | 13.51 | 13.73 | 13.44 | 13.62 | 5.425M |
| Aug 28, 2026 | 14.11 | 14.24 | 13.43 | 13.73 | 3.907M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0095 |
| Brainstorm Cell Therapeutics, Inc. | 0.9302 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.70 |
| Clene, Inc. | 4.08 |
Price Related Metrics
| PEG Ratio | -1.348 |
| Price to Book Value | 21.09 |
| Earnings Yield | -6.68% |
| Market Cap | 13.29B |
| PEGY Ratio | -1.348 |